This is to inform that due to some circumstances beyond the organizer control, “2nd Edition of International Conference and Expo on Clinical Microbiology” (ICCM 2023) Hybrid Event scheduled during June 23-24, 2023 | Rome, Italy has been postponed. The updated dates and venue will be displayed shortly.
Your registration can be transferred to the next edition, if you have already confirmed your participation at the event.
For further details, please contact us at clinical-microbiology@magnusconference.com or call +1 (702) 988 2320.
Pharmaceutical microbiology is a discipline of microbiology that focuses on applications. It entails the investigation of microorganisms involved in the production of pharmaceuticals, such as reducing the number of microorganisms in a process environment, removing microorganisms and microbial by-products such as exotoxin and endotoxin from water and other starting materials, and ensuring the sterility of the finished pharmaceutical product. Pharmaceutical microbiology is concerned with drug safety. Pathogenic bacteria, fungus (yeasts and moulds), and microorganism-produced chemicals are all potential contaminants of medicines, while strict, regulated methods are in place to reduce the danger.
Title : Managing bacterial eradication in disease and survival for life support systems on earth and space
AC Matin, Stanford University, United States
Title : Buffers and homeostasis: A key to maintaining health
Jawad Alzeer, University of Zurich, Switzerland
Title : An update of Lyme disease with particular reference to low endemic areas in Canada
Muhammad Morshed, University of British Columbia, Canada
Title : Antimicrobial activity of Zinc oxide nano particles against multi drug resistant Escherichia coli clinical isolates
Noha Tharwat Abou El Khier, Mansoura University, Egypt
Title : Microbial adhesion capacity on orthopedic implants
Bohinc Klemen, Faculty of Health Sciences, University of Ljubljana, Slovenia
Title : Evaluation of the anti-diabetic potential of probiotic lactobacillus fermentum (pri 29) isolated from cameroonian fermented cow milk in alloxan induced diabetes type-1 mice model
Tanyi Pride Bobga, University of Buea, Cameroon